TP53 codon 72 polymorphism and susceptibility to cervical cancer in the chinese population: An update meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 6, 2015, Pages 9055-9062

  Li, Bing ^a   Wang, Xin ^a   Chen, Hong ^a   Shang, Li Xin ^a   Wu, Nan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cervical cancer; Codon 72; Meta analysis; Polymorphism; TP53

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P53;

ARTICLE; CANCER RISK; CHINESE BIOMEDICAL DATABASE; CNKI DATABASE; CODON; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAN CHINESE; HUMAN; META ANALYSIS; SENSITIVITY ANALYSIS; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; WANFANG DATABASE;

EID: 84938306888     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay F, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Li J, Kang LN, Qiao YL. Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev 2011; 12: 1149-1153.
3. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-749.
4. Bosch FX, Munoz N, de Sanjose S, Navarro C, Moreo P, Ascunce N. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 1993; 2: 415-422.
5. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87: 796-802.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
7. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
8. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-365.
9. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-1100.
10. Langerod A, Bukholm IR, Bregard A, Lønning PE, Andersen TI, Rognum TO. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol Biomarkers Prev 2002; 11: 1684-1688.
11. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009; 101: 24-36.
12. Sjalander A, Birgander R, Saha N, Beckman L, Beckman G. p53 polymorphisms and haplotypes show distinct differences between major ethnic groups. Hum Hered 1994: 46: 41-48.
13. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivelä A. Is p53 polymorphism maintained by natural selection? Hum Hered 1994: 44: 266-270.
14. Sjalander A, Birgander R, Kivela A, Beckman G. p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 1995: 45: 144-149.
15. Arbel-Alon S, Menczer J, Feldman N, Glezerman M, Yeremin L, Friedman E. Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women. Int J Gynecol Cancer 2002: 12: 741-744.
16. Inserra P, Abrahamsen M, Papenfuss M, Giuliano AR. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk. Int J STD AIDS 2003: 14: 800-804.
17. Malisic E, Jankovic R, Brotto K, Radulovic S. TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women. Arch Gynecol Obstet 2013; 288: 621-625.
18. Sousa H, Santos AM, Pinto D, Medeiros R. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 2007; 20: 731-741.
19. Zheng XZ, Yang AQ, Pan XL, Zheng LL, Wang XL, Zhou QY. Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. Eur J Cancer Prev 2008; 17: 460-646.
20. Zhou X, Han S, Wang S, Chen X, Dong J, Shi X. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. Gynecol Oncol 2009; 114: 327-331.
21. Yao N, Zeng H, Lu J. Correlation between p53 condon72 polymorphism and cervical cancer. Acta Academiae Zunyi 2008; 1: 3-5.
22. Li CY, Liu JH, Huang BJ. Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer. Ai Zheng 2004; 23: 1396-1399.
23. Qie M, Zhang Y, Wu J. Study on the relationship between cervical cancer and p53 codon 72 polymorphism. Hua Xi Yi Ke Da Xue Xue Bao 2002; 33: 274-275.
24. Hou MM, Xi MR, Cao ZY, Yang KX, Sun ZL. P53 codon 72 polymorphism in cervical cancers and its correlation with HPV16, 18E6. Sichuan Da Xue Xue Bao Yi Xue Ban 2006; 37: 404-407.
25. Wu MT, Liu CL, Ho CK, Wu TN. Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. J Formos Med Assoc 2004; 103: 337-343.
26. Wang XL, Pan XL, Gao ZB, Zheng XZ, Li HA, Jiang JF. Correlation between P53 Condon72 polymorphism and cervical carcinoma among Uigur and Han People. J Shihezi University 2004; 4: 340-344.
27. Ngan HY, Liu VW, Liu SS. Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer 1999; 80: 1828-1829.
28. Yang YC, Chang CL, Chen ML. Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol Obstet Invest 2001; 51: 197-201.
29. Jiang P, Liu J, Zeng X, Li W, Tang JX. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women. Cancer Genet Cytogenet 2001; 197: 174-178.
30. Chen CC, Ding XH, Cai HB. HPV16 infection and p53 codon72 polymorphism in cervical cancer and precursor lesions. Chin Modern Med 2012; 19: 9-10.
31. Li J, Zheng QQ, Wang P. Relation between p53 codon 72 polymorphism and liability of squamous cervical cancer in Han population of Shaanxi Province: case-control study. J Fourth Mil Med Univ 2006; 27: 1499-1501.
32. Yang M, Xu JJ. Study on the correlation between p53 codon 72 polymorphism and cervical cancer in Mongolian women population. Med Recapitulate 2011; 17: 3352-3354.
33. Zhou X, Gu Y, Zhang SL. Association Between p53 codon 72 Polymorphism and Cervical Cancer Risk Among Asians: a Huge Review and Meta-analysis. Asian Pac J Cancer Prev 2012; 13: 4909-4914.